Form 4 for ICCC IMMUCELL CORP /DE/
Accepted 2026-06-22 08:33:34 ET · period of report 2026-06-18 · accession 0001437749-26-021258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 08:33 | 2026-06-18 | ICCC | te Boekhorst Paul Francis Olivier | Pres, CEO, Dir | P - Purchase | $9.49 | +8,000 | 17.8K | +82% | +$76.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $.01 per share | 2026-06-18 | P | A | 8,000 | $9.49 | 17,785 | D | — | — |